ASRT (STOCKS)
Assertio Holdings, Inc. Common Stock
$18.010000
-0.010000 (-0.06%)
Prev close: $18.020000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Mark L. Reisenauer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $116.14M
- Employees
- 30
- P/E (TTM)
- -3.66
- P/B (TTM)
- 1.23
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.86 | $-2.76 | +0.9042 | +32.71% |
|
Sep 2025 (Q3)
|
$1.80 | $-1.30 | +3.1005 | +238.41% |
|
Jun 2025 (Q2)
|
$-2.55 | $-1.16 | -1.3872 | -119.30% |
|
Mar 2025 (Q1)
|
$-0.60 | $-0.92 | +0.3180 | +34.64% |
Financial Statements
| Revenues | $118.71M |
| Benefits Costs and Expenses | $148.65M |
| Costs And Expenses | $140.25M |
| Nonoperating Income/Loss | -$8.40M |
| Operating Expenses | $140.25M |
| Selling, General, and Administrative Expenses | $69.00M |
| Research and Development | $1.69M |
| Other Operating Expenses | $69.56M |
| Operating Income/Loss | -$21.54M |
| Income/Loss From Continuing Operations After Tax | -$30.38M |
| Income/Loss From Continuing Operations Before Tax | -$29.94M |
| Income Tax Expense/Benefit | $435.00K |
| Income Tax Expense/Benefit, Current | $435.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$30.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$30.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$30.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.74 |
| Diluted Earnings Per Share | -$4.74 |
| Basic Average Shares | 6,403,000 |
| Diluted Average Shares | 6,403,000 |
| Assets | $266.97M |
| Current Assets | $216.65M |
| Inventory | $24.12M |
| Other Current Assets | $192.53M |
| Noncurrent Assets | $50.32M |
| Fixed Assets | $444.00K |
| Intangible Assets | $48.91M |
| Other Non-current Assets | $972.00K |
| Liabilities | $173.02M |
| Current Liabilities | $127.51M |
| Accounts Payable | $9.01M |
| Wages | $2.72M |
| Other Current Liabilities | $115.78M |
| Noncurrent Liabilities | $45.51M |
| Equity | $93.95M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $93.95M |
| Liabilities And Equity | $266.97M |
| Net Cash Flow From Operating Activities | -$28.18M |
| Net Cash Flow From Operating Activities, Continuing | -$28.18M |
| Net Cash Flow From Investing Activities | -$11.99M |
| Net Cash Flow From Investing Activities, Continuing | -$11.99M |
| Net Cash Flow From Financing Activities | -$189.00K |
| Net Cash Flow From Financing Activities, Continuing | -$189.00K |
| Net Cash Flow | -$40.36M |
| Net Cash Flow, Continuing | -$40.36M |
| Comprehensive Income/Loss | -$30.38M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$30.38M |
| Other Comprehensive Income/Loss | $0.00 |